Genfit advances nangibotide Phase 2 clinical investigation in Aclf
Genfit SA said it is advancing nangibotide in a Phase 2 clinical investigation in Aclf.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.